Intrinsic Edge Capital Management’s Haemonetics HAE Stock Holding History

Intrinsic Edge Capital Management’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-150,351	Closed	-$11.2M	–	111
2025 Q2	$11.2M	Buy	+150,351	New	+$9.95M	1.57%	24
2025 Q1	–	Sell	-187,330	Closed	-$14.6M	–	93
2024 Q4	$14.6M	Buy	187,330 +78,736	+73%	+$6.32M	1.78%	19
2024 Q3	$8.73M	Sell	108,594 -1,406	-1%	-$114K	1.05%	34
2024 Q2	$9.1M	Sell	110,000 -10,000	-8%	-$880K	0.82%	40
2024 Q1	$10.2M	Buy	+120,000	New	+$9.42M	0.8%	48
2023 Q1	–	Sell	-126,849	Closed	-$9.98M	–	166
2022 Q4	$9.98M	Sell	126,849 -25,568	-17%	-$2.06M	0.99%	39
2022 Q3	$11.3M	Buy	+152,417	New	+$10.9M	1.23%	28

Other funds holding HAE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Intrinsic Edge Capital Management's HAE Position: Q3 2025 in Review

Intrinsic Edge Capital Management sold out of Haemonetics (HAE) in Q3 2025, closing a stake of 150,351 shares — an estimated $11.2M sold.

Intrinsic Edge Capital Management first reported a position in HAE in Q3 2022 and held it in 7 quarters. The position peaked at $14.6M in Q4 2024. 301 funds tracked by Wall St. Rank hold HAE as of Q3 2025.

Intrinsic Edge Capital Management reported no remaining Haemonetics position as of Q3 2025 after selling out during the quarter.
Intrinsic Edge Capital Management sold 150,351 Haemonetics shares in Q3 2025, an estimated $11.2M.
Intrinsic Edge Capital Management first reported a position in Haemonetics in Q3 2022 and held it in 7 quarters.
Intrinsic Edge Capital Management's Haemonetics position peaked at $14.6M in Q4 2024.
301 funds tracked by Wall St. Rank held Haemonetics as of Q3 2025.

Based on Intrinsic Edge Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.